157 related articles for article (PubMed ID: 36597379)
1. Complete response with combined therapy in a patient with brain metastasis from nasopharyngeal carcinoma: case report and literature review.
Jiang L; Zhang C
J Int Med Res; 2023 Jan; 51(1):3000605221147187. PubMed ID: 36597379
[TBL] [Abstract][Full Text] [Related]
2. Central nervous system metastasis from nasopharyngeal carcinoma: a report of two patients and a review of the literature.
Ngan RK; Yiu HH; Cheng HK; Chan JK; Sin VC; Lau WH
Cancer; 2002 Jan; 94(2):398-405. PubMed ID: 11905411
[TBL] [Abstract][Full Text] [Related]
3. Maintenance chemotherapy using S-1 following definitive chemoradiotherapy in patients with N3 nasopharyngeal carcinoma.
Zong J; Xu H; Chen B; Guo Q; Xu Y; Chen C; Weng Y; Zheng W; Pan J; Lin S
Radiat Oncol; 2019 Oct; 14(1):182. PubMed ID: 31640719
[TBL] [Abstract][Full Text] [Related]
4. Case report: Leptomeningeal metastasis of advanced nasopharyngeal carcinoma treated with chemoimmunotherapy.
Shi M; Sun D; Ma X; Liu J; Zhang Y; Liu T; Chen X; Mo S; Zhao Y; Zhang L
Hum Vaccin Immunother; 2023 Dec; 19(3):2294579. PubMed ID: 38111107
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy.
Finazzi T; Rordorf T; Ikenberg K; Huber GF; Guckenberger M; Garcia Schueler HI
BMC Cancer; 2018 Apr; 18(1):395. PubMed ID: 29625593
[TBL] [Abstract][Full Text] [Related]
6. Nasopharyngeal Carcinoma in Children, Current Treatment Approach.
Ben-Ami T
J Pediatr Hematol Oncol; 2024 Apr; 46(3):117-124. PubMed ID: 38447121
[TBL] [Abstract][Full Text] [Related]
7. Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults: preliminary results from the prospective, multicenter study NPC-2003-GPOH/DCOG.
Buehrlen M; Zwaan CM; Granzen B; Lassay L; Deutz P; Vorwerk P; Staatz G; Gademann G; Christiansen H; Oldenburger F; Tamm M; Mertens R
Cancer; 2012 Oct; 118(19):4892-900. PubMed ID: 22359313
[TBL] [Abstract][Full Text] [Related]
8. Comparison of induction chemotherapy plus concurrent chemoradiotherapy and induction chemotherapy plus radiotherapy in locally advanced nasopharyngeal carcinoma.
Wang Q; Xu G; Xia Y; Zuo J; Zeng G; Xue Z; Cao R; Xiong W; Li W
Oral Oncol; 2020 Dec; 111():104925. PubMed ID: 32721816
[TBL] [Abstract][Full Text] [Related]
9. The Five-Year Survival Rate of Patients with Nasopharyngeal Carcinoma Based on Tumor Response after Receiving Neoadjuvant Chemotherapy, Followed by Chemoradiation, in Indonesia: A Retrospective Study.
Dwijayanti F; Prabawa A; Besral ; Herawati C
Oncology; 2020; 98(3):154-160. PubMed ID: 31995803
[TBL] [Abstract][Full Text] [Related]
10. [Clinical aspects of brain metastases from nasopharyngeal carcinoma].
Elloumi F; Ben Amor M; Ghorbel L; Mnif H; Boudawara T; Ghorbel AM; Frikha M; Daoud J
Cancer Radiother; 2013 Dec; 17(8):768-70. PubMed ID: 24269014
[TBL] [Abstract][Full Text] [Related]
11. A phase II multicenter randomized controlled trial to compare standard chemoradiation with or without recombinant human endostatin injection (Endostar) therapy for the treatment of locally advanced nasopharyngeal carcinoma: Long-term outcomes update.
Li Y; Tian Y; Jin F; Wu W; Long J; Ouyang J; Zhou Y
Curr Probl Cancer; 2020 Feb; 44(1):100492. PubMed ID: 32035692
[TBL] [Abstract][Full Text] [Related]
12. Sequential induction chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: the three-year report of a phase II, single center, randomized, non-inferiority trial.
Yang Z; Cai Z; Cai Q; Hong Y; Zhang C; Huang K; Lin Z; Li M
Cancer Med; 2021 Jun; 10(12):3886-3895. PubMed ID: 33955190
[TBL] [Abstract][Full Text] [Related]
13. Role of chemotherapy in stage IIb nasopharyngeal carcinoma.
Pan XB; Zhu XD
Chin J Cancer; 2012 Dec; 31(12):573-8. PubMed ID: 22776232
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of induction chemotherapy with vinorelbine plus cisplatin (NP) or docetaxel plus cisplatin (TP) combined with concurrent chemoradiotherapy for patients with locally advanced nasopharyngeal carcinoma].
Han SH; Yu L; Zhang Z; Zhang PJ; Song HP; Guo CY
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):623-6. PubMed ID: 24314223
[TBL] [Abstract][Full Text] [Related]
15. [Concurrent chemoradiotherapy followed by adjuvant chemotherapy for stage III-IVa nasopharyngeal carcinoma].
Hu QY; Liu P; Wang L; Fu ZF
Ai Zheng; 2007 Apr; 26(4):394-7. PubMed ID: 17430659
[TBL] [Abstract][Full Text] [Related]
16. Brain Metastasis from Nasopharyngeal Carcinoma Treated with Stereotactic Radiosurgery.
Park SH; Yoon SY; Park KS; Hwang JH; Hwang SK
World Neurosurg; 2019 Jun; 126():160-163. PubMed ID: 30877007
[TBL] [Abstract][Full Text] [Related]
17. Prolonged complete remission after induction chemotherapy followed by chemoradiation with tomotherapy in metastatic nasopharyngeal cancer.
Agnese D; Belgioia L; Bacigalupo A; Marcenaro M; Vecchio S; Agostinelli S; Morbelli S; Corvò R
Anticancer Res; 2014 Sep; 34(9):5075-8. PubMed ID: 25202093
[TBL] [Abstract][Full Text] [Related]
18. Using neoadjuvant chemotherapy and replanning intensity-modulated radiotherapy for nasopharyngeal carcinoma with intracranial invasion to protect critical normal tissue.
Niu X; Chang X; Gao Y; Hu C; Kong L
Radiat Oncol; 2013 Oct; 8():226. PubMed ID: 24083351
[TBL] [Abstract][Full Text] [Related]
19. Survival without adjuvant chemotherapy for selected patients with stage II and III nasopharyngeal carcinoma after concurrent chemoradiotherapy alone.
Wu JS; Tsai YC; Jian JJ; Chen HH; Horng CF; Cheng SH
Head Neck; 2018 Sep; 40(9):2070-2077. PubMed ID: 29756398
[TBL] [Abstract][Full Text] [Related]
20. Unusual axillary metastasis of recurrent nasopharyngeal cancer: A case report.
Kuo DY; Chang MH; Wang SY; Hsieh PY; Shueng PW
Medicine (Baltimore); 2017 May; 96(20):e6854. PubMed ID: 28514301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
